Population . | Defining Markers . | Immune Target/Function . | Alternative Molecules . | References . |
---|---|---|---|---|
Th1 | CXCR3+CCR4− | Intracellular microbes | CD226, PD-1, T-bet | (3, 14, 15–17) |
Th2 | CCR4+CXCR3− | Extracellular parasites | GATA3 | (3, 14) |
Th17 | CCR6+CD161+ | Extracellular microbes/commensal | ICOS, RORC2 | (2, 18–20) |
Tfh | CXCR5+ | B cell maturation | ICOS, PD-1, CD62L | (5, 21–23) |
FOXP3 Treg | FOXP3+CD25hiCD127lo/− | Tolerance/immune suppression | TIGIT, CTLA-4, p-STAT5 | (4, 7, 8, 24, 25) |
Memory Tr1 | CD45RA−LAG3+CD49b+ | Peripheral Tolerance/myeloid killing | ICOS, PD-1, CD226 | (4, 6, 26, 27) |
Population . | Defining Markers . | Immune Target/Function . | Alternative Molecules . | References . |
---|---|---|---|---|
Th1 | CXCR3+CCR4− | Intracellular microbes | CD226, PD-1, T-bet | (3, 14, 15–17) |
Th2 | CCR4+CXCR3− | Extracellular parasites | GATA3 | (3, 14) |
Th17 | CCR6+CD161+ | Extracellular microbes/commensal | ICOS, RORC2 | (2, 18–20) |
Tfh | CXCR5+ | B cell maturation | ICOS, PD-1, CD62L | (5, 21–23) |
FOXP3 Treg | FOXP3+CD25hiCD127lo/− | Tolerance/immune suppression | TIGIT, CTLA-4, p-STAT5 | (4, 7, 8, 24, 25) |
Memory Tr1 | CD45RA−LAG3+CD49b+ | Peripheral Tolerance/myeloid killing | ICOS, PD-1, CD226 | (4, 6, 26, 27) |